Hosted on MSN5m
Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) in Q4 CY2024, with sales flat year on year at $594 million. Its ...
Hosted on MSN24m
Humana (NYSE:HUM) Beats Q4 Sales Targets, Guides for Strong Full-Year Sales
Health insurance company Humana (NYSE:HUM) announced in Q4 CY2024, with sales up 13.5% year on year to $29.21 billion. The ...
IPG Photonics’s (NASDAQ:IPGP) Q4 Sales Top Estimates But Quarterly Revenue Guidance Significantly Misses Expectations
Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, but ...